- Home
- MBBC vs DYAI Comparison
MBBC vs DYAI Comparison
Compare MBBC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBBC
- DYAI
- Stock Information
- Founded
- MBBC 1902
- DYAI 1979
- Country
- MBBC United States
- DYAI United States
- Employees
- MBBC N/A
- DYAI N/A
- Industry
- MBBC Banks
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MBBC Finance
- DYAI Health Care
- Exchange
- MBBC Nasdaq
- DYAI Nasdaq
- Market Cap
- MBBC 29.3M
- DYAI 28.3M
- IPO Year
- MBBC N/A
- DYAI 2004
- Fundamental
- Price
- MBBC $10.05
- DYAI $0.99
- Analyst Decision
- MBBC
- DYAI Strong Buy
- Analyst Count
- MBBC 0
- DYAI 1
- Target Price
- MBBC N/A
- DYAI $6.00
- AVG Volume (30 Days)
- MBBC 10.2K
- DYAI 62.0K
- Earning Date
- MBBC 08-22-2025
- DYAI 08-12-2025
- Dividend Yield
- MBBC N/A
- DYAI N/A
- EPS Growth
- MBBC 103.56
- DYAI N/A
- EPS
- MBBC 0.22
- DYAI N/A
- Revenue
- MBBC $6,591,743.00
- DYAI $3,554,344.00
- Revenue This Year
- MBBC N/A
- DYAI $22.56
- Revenue Next Year
- MBBC N/A
- DYAI $30.95
- P/E Ratio
- MBBC $45.54
- DYAI N/A
- Revenue Growth
- MBBC N/A
- DYAI 57.59
- 52 Week Low
- MBBC $6.38
- DYAI $0.91
- 52 Week High
- MBBC $12.00
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- MBBC N/A
- DYAI 46.85
- Support Level
- MBBC N/A
- DYAI $0.91
- Resistance Level
- MBBC N/A
- DYAI $1.02
- Average True Range (ATR)
- MBBC 0.00
- DYAI 0.05
- MACD
- MBBC 0.00
- DYAI 0.01
- Stochastic Oscillator
- MBBC 0.00
- DYAI 35.07
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.